ESCROW AGREEMENTEscrow Agreement • December 31st, 2018 • China Cardiovascular Focus LTD • Biological products, (no disgnostic substances) • New York
This Escrow Agreement (“Agreement”) is made and entered into as of December 21, 2018, by and between: Windtree Therapeutics, Inc., a Delaware corporation, (“Parent”), Lee’s Pharmaceutical Holdings Limited (referred to collectively with its affiliate, China Cardiovascular Focus Limited, as “LPHL”) and Continental Stock Transfer & Trust Company, a New York corporation (the “Escrow Agent”).
Joint Filing AgreementJoint Filing Agreement • December 31st, 2018 • China Cardiovascular Focus LTD • Biological products, (no disgnostic substances)
This Agreement may be executed in two or more counterparts, each of which shall be deemed an original but all of which together will constitute one and the same instrument.
